Civatech Oncology, Inc.
Publicly observedMorrisville, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | Morrisville | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Civatech Oncology, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | NCJMMLLMRND9 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant17 Sept 2026Publicly observed
NIH SBIR/STTR award: CivaDerm Non-Melanoma Skin Cancer Radiation Therapy Device
USD 1,205,017.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant13 Sept 2016Publicly observed
NIH SBIR/STTR award: Commercializing CivaSheet for Pancreatic Cancer Patients
USD 1,017,318.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.